Cardiac transplantation at Duke University Medical Center.

G. Michael Felker, Adrian F. Hernandez, Joseph G. Rogers, Stuart D. Russell, Nancy L. Reinsmoen, Paul Rosenberg, Jonathan A. Hata, Andrew J. Lodge, Carmelo A. Milano

Research output: Contribution to journalArticle

Abstract

Since beginning cardiac transplantation in 1985, Duke University Medical Center has performed 485 de novo heart transplants in adult recipients. Our program has broadened the access of patients to transplantation through the aggressive use of ventricular assist devices as bridge to transplant in patients with acute heart failure and shock, as well as through the introduction of an alternate list program for suboptimal transplant candidates. Despite this broadening of the recipient pool, our long-term outcomes have remained good, with 5-year survival of 75% and 10-year survival of 51%. Continued advances in immunosuppression and treatment for cardiac allograft vasculopathy seem likely to continue to improve long-term outcomes from cardiac transplantation. Expanding indications for VAD support (such as destination therapy) and continued improvements in this technology seem certain to impact patient selection and therefore the results of transplantation in the future. Appropriate triage of patients with advanced heart failure among available therapies will be the cornerstone of optimizing outcomes in this critically ill patient population.

Original languageEnglish (US)
Pages (from-to)235-241
Number of pages7
JournalClinical transplants
StatePublished - 2004
Externally publishedYes

Fingerprint

Heart Transplantation
Transplants
Heart Failure
Transplantation
Heart-Assist Devices
Survival
Triage
Critical Illness
Immunosuppression
Patient Selection
Allografts
Shock
Therapeutics
Technology
Population

Cite this

Felker, G. M., Hernandez, A. F., Rogers, J. G., Russell, S. D., Reinsmoen, N. L., Rosenberg, P., ... Milano, C. A. (2004). Cardiac transplantation at Duke University Medical Center. Clinical transplants, 235-241.

Cardiac transplantation at Duke University Medical Center. / Felker, G. Michael; Hernandez, Adrian F.; Rogers, Joseph G.; Russell, Stuart D.; Reinsmoen, Nancy L.; Rosenberg, Paul; Hata, Jonathan A.; Lodge, Andrew J.; Milano, Carmelo A.

In: Clinical transplants, 2004, p. 235-241.

Research output: Contribution to journalArticle

Felker, GM, Hernandez, AF, Rogers, JG, Russell, SD, Reinsmoen, NL, Rosenberg, P, Hata, JA, Lodge, AJ & Milano, CA 2004, 'Cardiac transplantation at Duke University Medical Center.', Clinical transplants, pp. 235-241.
Felker GM, Hernandez AF, Rogers JG, Russell SD, Reinsmoen NL, Rosenberg P et al. Cardiac transplantation at Duke University Medical Center. Clinical transplants. 2004;235-241.
Felker, G. Michael ; Hernandez, Adrian F. ; Rogers, Joseph G. ; Russell, Stuart D. ; Reinsmoen, Nancy L. ; Rosenberg, Paul ; Hata, Jonathan A. ; Lodge, Andrew J. ; Milano, Carmelo A. / Cardiac transplantation at Duke University Medical Center. In: Clinical transplants. 2004 ; pp. 235-241.
@article{3084122ca3ff4a2facdc804c02be7782,
title = "Cardiac transplantation at Duke University Medical Center.",
abstract = "Since beginning cardiac transplantation in 1985, Duke University Medical Center has performed 485 de novo heart transplants in adult recipients. Our program has broadened the access of patients to transplantation through the aggressive use of ventricular assist devices as bridge to transplant in patients with acute heart failure and shock, as well as through the introduction of an alternate list program for suboptimal transplant candidates. Despite this broadening of the recipient pool, our long-term outcomes have remained good, with 5-year survival of 75{\%} and 10-year survival of 51{\%}. Continued advances in immunosuppression and treatment for cardiac allograft vasculopathy seem likely to continue to improve long-term outcomes from cardiac transplantation. Expanding indications for VAD support (such as destination therapy) and continued improvements in this technology seem certain to impact patient selection and therefore the results of transplantation in the future. Appropriate triage of patients with advanced heart failure among available therapies will be the cornerstone of optimizing outcomes in this critically ill patient population.",
author = "Felker, {G. Michael} and Hernandez, {Adrian F.} and Rogers, {Joseph G.} and Russell, {Stuart D.} and Reinsmoen, {Nancy L.} and Paul Rosenberg and Hata, {Jonathan A.} and Lodge, {Andrew J.} and Milano, {Carmelo A.}",
year = "2004",
language = "English (US)",
pages = "235--241",
journal = "Clinical transplants",
issn = "0890-9016",
publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Cardiac transplantation at Duke University Medical Center.

AU - Felker, G. Michael

AU - Hernandez, Adrian F.

AU - Rogers, Joseph G.

AU - Russell, Stuart D.

AU - Reinsmoen, Nancy L.

AU - Rosenberg, Paul

AU - Hata, Jonathan A.

AU - Lodge, Andrew J.

AU - Milano, Carmelo A.

PY - 2004

Y1 - 2004

N2 - Since beginning cardiac transplantation in 1985, Duke University Medical Center has performed 485 de novo heart transplants in adult recipients. Our program has broadened the access of patients to transplantation through the aggressive use of ventricular assist devices as bridge to transplant in patients with acute heart failure and shock, as well as through the introduction of an alternate list program for suboptimal transplant candidates. Despite this broadening of the recipient pool, our long-term outcomes have remained good, with 5-year survival of 75% and 10-year survival of 51%. Continued advances in immunosuppression and treatment for cardiac allograft vasculopathy seem likely to continue to improve long-term outcomes from cardiac transplantation. Expanding indications for VAD support (such as destination therapy) and continued improvements in this technology seem certain to impact patient selection and therefore the results of transplantation in the future. Appropriate triage of patients with advanced heart failure among available therapies will be the cornerstone of optimizing outcomes in this critically ill patient population.

AB - Since beginning cardiac transplantation in 1985, Duke University Medical Center has performed 485 de novo heart transplants in adult recipients. Our program has broadened the access of patients to transplantation through the aggressive use of ventricular assist devices as bridge to transplant in patients with acute heart failure and shock, as well as through the introduction of an alternate list program for suboptimal transplant candidates. Despite this broadening of the recipient pool, our long-term outcomes have remained good, with 5-year survival of 75% and 10-year survival of 51%. Continued advances in immunosuppression and treatment for cardiac allograft vasculopathy seem likely to continue to improve long-term outcomes from cardiac transplantation. Expanding indications for VAD support (such as destination therapy) and continued improvements in this technology seem certain to impact patient selection and therefore the results of transplantation in the future. Appropriate triage of patients with advanced heart failure among available therapies will be the cornerstone of optimizing outcomes in this critically ill patient population.

UR - http://www.scopus.com/inward/record.url?scp=33745274463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745274463&partnerID=8YFLogxK

M3 - Article

C2 - 16704154

AN - SCOPUS:33745274463

SP - 235

EP - 241

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -